Dipentylamine

Dipentylamine

SCHEMBL4467209

CCCCCNCCCCC.CCCN

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.77
ALDH1A1 P00352 1/20 0.77
CA12 O43570 4/20 0.58
CA6 P23280 4/20 0.58
CA7 P43166 4/20 0.58
CA9 Q16790 4/20 0.58
CA14 Q9ULX7 4/20 0.58
CA5B Q9Y2D0 4/20 0.58
CA2 P00918 3/20 0.58
CA4 P22748 3/20 0.58
CA5A P35218 3/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
F13A1 P00488 2/20 0.58
CYP1A2 P05177 2/20 0.58
ALOX15 P16050 2/20 0.58
THPO P40225 2/20 0.58
CASP2 P42575 2/20 0.58
RECQL P46063 2/20 0.58
CYP2C19 P33261 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propylamine SCHEMBL4469240 0.97 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
Propylamine SCHEMBL6656822 0.97 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
Propylamine SCHEMBL4465246 0.97 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
SCHEMBL1015325 0.94
SCHEMBL25409467 0.92 ALDH1A1 (0.72) TSHRALDH1A1CA12CA6CA7
Ethylenediamine SCHEMBL5462538 0.92 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
Ethylenediamine SCHEMBL141740 0.92 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
SCHEMBL4474440 0.92 TSHR (0.72) TSHRALDH1A1CA12CA6CA7
SCHEMBL11794778 0.92 ALDH1A1 (0.72) TSHRALDH1A1CA12CA6CA7
SCHEMBL444731 0.92 ALDH1A1 (0.72) TSHRALDH1A1CA12CA6CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2098316-A2 Metal nanoparticles stabilized with a bident amine Xerox Corporation (US) 2009-09-09 EP claimed
US-20090214764-A1 METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE XEROX CORPORATION (US) 2009-08-27 US claimed
US-10829442-B2 Process for the preparation of carbamates TAMINCO BVBA (BE) 2020-11-10 US disclosed
US-20190169115-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES TAMINCO BVBA (BE) 2019-06-06 US disclosed
EP-3279185-B1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES TAMINCO BVBA (BE) 2018-11-14 EP disclosed
EP-3279185-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES Taminco bvba (BE) 2018-02-07 EP disclosed
EP-2098316-A2 Metal nanoparticles stabilized with a bident amine Xerox Corporation (US) 2009-09-09 EP disclosed
US-20090214764-A1 METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE XEROX CORPORATION (US) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10829442-B2 Process for the preparation of carbamates CPS1, GLUL, CBR3 TSHR 1833/4885ALDH1A1 932/4885CA12 1081/4885
US-20190169115-A1 IMPROVED PROCESS FOR THE PREPARATION OF CARBAMATES CPS1, GLUL, C9 TSHR 1994/4885ALDH1A1 1254/4885CA12 1017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.